It’s finally here!
Kybella™ is a new injectable treatment for submental fullness (double chin) that can significantly improve chin contouring without the invasiveness and downtime of surgical options. Kybella was approved by the U.S. Food and Drug Administration (FDA) in May 2015 for the reduction of submental fat.
Kybella facts
How does it work?
Kybella is a synthetic formulation of deoxycholic acid, which is a substance naturally synthesized by our body and used to break down and absorb dietary fat. Kybella has been under development for more than 9 years, and has been the subject of over 20 clinical studies involving more than 2600 patients. When properly injected in the chin area, it has been shown to dissolve submental fat (which causes double chin) and result in significant cosmetic improvement by creating a more streamline contour along the jawline.
What causes submental fat (double chin)? Who is affected?
The major factors seem to be genetics, natural aging or weight gain. Double chin can cause an older and heavier look and according to a 2014 survey by the American Society for Dermatologic Surgery approximately 70% of consumers report being bothered by submental fullness.
What other options exist to reduce submental fat?
The only effective options to treat submental fat before Kybella were surgery or liposuction.
How many treatments does it take?
Kybella is administered by injections into the fat under the chin through a series of treatments spaced no less than one month apart. The treatment plan is tailored to the desired outcome by the treating physician. The total number of treatments varies–typically in the range between 2 and 5. We expect that most patients will receive two treatments spaced 1-2 months apart, but your physician will determine the best regime during your consultation based on your physiology and goals.
How quickly do the results appear?
Typically results appear within weeks to months, and keep improving as additional treatments are administered.



